Patients who lose 30, 50, or 80 pounds through GLP-1 therapy often develop loose skin or stubborn fat deposits
Early studies suggest that GLP-1 receptor agonists, like semaglutide, may be beneficial for people with IBD
This means any substance that: Is not approved by any governmental regulatory health authority for human therapeutic use (e.g., drugs under pre-clinical or clinical development)
LiMWangXLiXChenHHuYZhangXet al
In fact, anakinra was associated with higher rates of acute kidney injury and significantly lower survival than the SOC.34 Although canakinumab showed histological improvement, it did not reduce mortality or change Lille or MELD scores [35]
Patients should speak with a qualified provider before considering any compound promoted for longevity, metabolism, or body composition